<DOC>
	<DOCNO>NCT00624858</DOCNO>
	<brief_summary>The purpose study determine whether combination naltrexone SR bupropion SR safe effective treatment major depression overweight obese subject .</brief_summary>
	<brief_title>A Study Naltrexone SR/ Bupropion SR Overweight Obese Subjects With Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Female male subject must 18 65 year age ; Have body mass index ( BMI ) great equal 27 less equal 43kg/m2 ; Meet criterion major depression Women childbearing potential , must nonlactating agree use effective contraception throughout study period 30 day discontinuation study drug ; Able comply require study procedure schedule ; Able speak read English ; Willing able give write informed consent Obesity know endocrine origin Serious medical condition History drug alcohol abuse dependence Use exclude concomitant medication History surgical device ( e.g . gastric banding ) intervention obesity ; History predisposition seizure Pregnant breastfeed woman plan become pregnant study period within 30 day discontinue study drug ; Planned surgical procedure impact conduct study ; Use investigational drug , device procedure within 30 day prior Screening ; Participation previous clinical trial conduct Orexigen Therapeutics ; Any condition opinion investigator make subject unsuitable inclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Depression</keyword>
	<keyword>depressed</keyword>
	<keyword>overweight</keyword>
	<keyword>obese</keyword>
</DOC>